Superworth

Supernus Pharmaceuticals EPS SUPN

Diluted earnings per share by quarter and over the last twelve months, from 2011.

Last 12 months, to Sep 30, 2026
−$0.77
Latest quarter, Q3 FY26
$0.35
Fiscal year 2025
−$0.68
−152% on the year before

Supernus Pharmaceuticals' earnings per share was −$0.77 over the twelve months to Sep 30, 2026.

In its latest quarter, Q3 FY26, it was $0.35.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.68−152%
FY2024$1.32n/a
FY2023$0.00−100%
FY2022$1.02+4%
FY2021$0.98−58%
FY2020$2.36+12%
FY2019$2.11+2%
FY2018$2.06+94%
FY2017$1.06−38%
FY2016$1.70+507%
FY2015$0.28n/a
FY2014−$0.27n/a
FY2013−$2.92n/a
FY2012−$7.72−126%
FY2011$30.23n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26$0.35n/a−$0.77
Q2 FY26−$1.01−353%−$1.92
Q1 FY26−$0.04n/a−$0.51
Q4 FY25−$0.07−126%−$0.68
Q3 FY25−$0.80−216%−$0.34
Q2 FY25$0.40+11%$1.15
Q1 FY25−$0.21n/a$1.11
Q4 FY24$0.27+1250%$1.32
Q3 FY24$0.69n/a$1.07
Q2 FY24$0.36n/a$0.09
Q1 FY24$0.00−100%−$0.29
Q4 FY23$0.02−95%$0.00

Against its peers

Companies in Drug Manufacturers - General nearest Supernus Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
SUPNSupernus Pharmaceuticals−$0.77
HRMYHarmony Biosciences$3.09−0% a year
PBHPrestige Consumer Healthcare$3.57−16% a year
ANIPANI Pharmaceuticals$4.70
NRIXNurix Therapeutics$2.31
PAHCPhibro Animal Health$2.44+107% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
OMEROmeros$1.52
OGNOrganon$0.76−60% a year
LQDALiquidia$1.39
Peer median$2.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Supernus Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.